How to Decrease Cardiovascular Mortality in Renal Transplant Recipients

Transplantation Proceedings

Volumn 38, Issue 9, 2006, Pages 2887-2892

  Ostovan, M A ^a   Fazelzadeh, A ^a   Mehdizadeh, A R ^a   Razmkon, A ^a   Malek Hosseini, S A ^a  

^a Southern Iran Organ Transplant Center Shiraz   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ANALYTIC METHOD; ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DIALYSIS; FOLLOW UP; GENETIC DISORDER; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERPARATHYROIDISM; HYPERTENSION; HYPERURICEMIA; IMMOBILIZATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MORTALITY; OBESITY; PRIORITY JOURNAL; PROTEINURIA; RECIPIENT; SMOKING; TOBACCO;

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; HUMANS; KIDNEY TRANSPLANTATION; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33750957946     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.091     Document Type: Article

References (48)

1. Wolfe R.A., Ashby V.B., Milford E.L., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaver transplant. N Engl J Med 341 (1999) 1725
2. Ojo A.O., Hanson J.A., Wolfe R.A., et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 57 (2000) 307
3. Arend S.M., Mallat M.J.K., Westendorp R.J.W., et al. Patient survival after renal transplantation, more than 25 years follow-up. Nephrol Dial Transplant 12 (1997) 1672
4. McLean D., Hay P., Woo Y.M., et al. Cardiovascular risk and renal transplantation: a mathematical model to explore future strategies. In: Timio M., Wizemann V., and Venanzi S. (Eds). Cardionephrology (2000), Cosenza Editoriale Bios 233
5. Raine A.E.G., Margreiter R., Brunner F.P., et al. Report on management of renal failure in Europe, XXII 1991. Nephrol Dial Transplant 7 suppl 2 (1992) 7
6. Kasiske B.L., Guijarro C., Massy Z.A., et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7 (1996) 158
7. McGregor E., Stewart G., Rodger R.S.C., et al. Early echocardiographic changes and survival following renal transplantation. Nephrol Dial Transplant 15 (2000) 93
8. Ducloux D., Motte G., Challier B., et al. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J Am Soc Nephrol 11 (2000) 134
9. Parfrey P.S., Foley R.N., and Rigatto C. Risk issues in renal transplantation: cardiac aspects. Transplant Proc 31 (1999) 291
10. Harnett J.S., Kent G.M., Foley R.N., et al. Cardiac function and haematocrit level. Am J Kidney Dis 25 suppl 1 (1995) S3
11. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837
12. Steinberg D., Parthasarathy S., Carew T.E., et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320 (1989) 915
13. Ligten berg G., Hene R.J., Blankestijn P.J., et al. Cardiovascular risk factors in renal transplant patients: Cyclosporin A versus tacrolimus. J Am Soc Nephrol 12 (2001) 368-373
14. Tse K.C., Lam M.F., Yip P.S., et al. A long-term study on hyperlipidemia in stable renal transplant recipients. Clin Transplant 18 (2004) 247
15. Wanner C., and Krane V. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005) 1640
16. Mason N.A., and Bailie G.R. HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 45 (2005) 119
17. Fellstrom B.C., Holdaa S.H., and Jardine A.G. Why do we need a statin trial in hemodialysis patients?. Kidney Int Suppl 84 (2003) S204
18. Lossey L., Asztlos L., Kinceses Z., et al. The importance of obesity and hyperlipidemia in patients with renal transplants. Int Urol Nephrol 30 (1998) 767
19. Johnson D.W., and Isbel N.M. The effect of obesity on renal transplant outcomes. Transplantation 74 (2002) 675
20. el-Agroudy A.E., Wafa E.W., and Gheith O.E. Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation 77 (2004) 1381
21. Guida B., and Trio R. Body composition and cardiovascular risk factors in pretransplant hemodialysis patients. Clin Nutr 23 (2004) 363
22. Raiss-Jalali G.A., Mehdizadeh A.R., Razmkon A., et al. Effect of body mass index at time of transplantation and weight gain after transplantation on allograft function in kidney transplant recipients in Shiraz. Transplant Proc 37 (2005) 2998
23. Piero Marchetti M.D. New-onset diabetes after transplantation. J Heart Lung Transplant 23 suppl 1 (2004) S194
24. Roozbeh J., Mehdizadeh A.R., Razmkon A., et al. Incidence of posttransplantation diabetes mellitus in kidney transplantation: a single-center experience. Transplant Proc 37 (2005) 3095
25. Perna A.F., Ingrosso D., and Molino D. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients-Italian initiative on uremic hyperhomocysteinemia (IIUH). J Nephrol 16 (2003) 516
26. Boots J.M., van Duijnhoven E.M., Christiaans M.H., et al. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients. Transpl Int 14 (2001) 370
27. Culleton B.F., Larson M.G., Wilson P.W.F., et al. Cardiovascular disease and mortality in a community based cohort with mild renal insufficiency. Kidney Int 56 (1999) 2214
28. Deligiannis A., Paschalidou E., Sakellariou G., et al. Changes in left ventricular anatomy during haemodialysis, continuous ambulatory peritoneal dialysis and after renal transplantation. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21 (1985) 185
29. Levin A., Thompson C.R., Ethier J., et al. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 34 (1999) 125
30. Graettinger J.S., Parsons R.L., and Campbell J.A. A correlation of clinical and hemodynamic studies in patients with mild and severe anemia with and without congestive heart failure. Ann Intern Med 58 (1963) 617
31. First M.R., Neylan J.F., Rocher L.L., et al. Hypertension after renal transplantation. J Am Soc Nephrol 4 suppl 8 (1994) S30
32. Aker S., Ivens K., Guo Z., et al. Cardiovascular complications after renal transplantation. Transplant Proc 30 (1998) 2039
33. Silverberg D.S., Blum M., Peer G., et al. Anemia during the predialysis period: a key to cardiac damage in renal failure. Nephron 80 (1998) 1
34. Sarnak M.J., and Levey A.S. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 35 suppl 1 (2000) S117
35. Reichel H., Zeier M., and Ritz E. Proteinuria after renal transplantation: pathogenesis and management. Nephrol Dial Transplant 19 (2004) 301
36. Varagunam M., Finney H., Trevitt R., et al. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am J Kidney Dis 43 (2004) 502
37. Block G.A., Hulbert-Shearon T.E., Levin N.W., et al. Association of serum phosphorous and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31 (1998) 607
38. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12 (2001) 2131
39. Thanakitcharu P., Fadda G.Z., Hajjar S.M., et al. The mechanism of the protective effect of verapamil in pancreatic islets of CRF rats. Endocrinology 129 (1991) 1749
40. Kalil R.S., Hudson S.L., and Gaston R.S. Determinants of cardiovascular mortality after renal transplantation: a role for cytomegalovirus. Am J Transplant 3 (2003) 79
41. Braun W., Phillips D., Vidt D., et al. Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 16 (1984) 603
42. Ramos E., Kasiske B., Alexander S., et al. The evaluation of candidates for renal transplantation. Transplantation 57 (1994) 490
43. Philipson J., Carpenter B., Itzkoff J., et al. Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 81 (1986) 630
44. Aker S., Ivens K., Guo Z., et al. Cardiovascular complications after renal transplantation. Transplant Proc 30 (1998) 2039
45. Markell M.S., Armenti V., Danovitch G., et al. Hyperlipidemia and glucose intolerance in the post-renal transplant patient. J Am Soc Nephrol 4 (1994) S37
46. American Diabetes Association. Clinical practice recommendations 2003: position statement: management of dyslipidemia in adults with diabetes. Diabetes Care 26 suppl 1 (2003) S83
47. Levey A.S., Beto J.A., Coronado B.E., et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here?. Am J Kidney Dis 32 (1998) 853
48. Pirsch J.D., Armbrust M.J., Knechtle S.J., et al. Obesity as a risk factor following renal transplantation. Transplantation 59 (1995) 631